Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurr
- This topic has 0 replies, 1 voice, and was last updated 4 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
https://www.ncbi.nlm.nih.gov/pubmed/31702638
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.